Literature DB >> 10780569

Clinical epidemiology and natural history of gastroesophageal reflux disease.

A Sonnenberg1, H B El-Serag.   

Abstract

In the MUSE classification of gastroesophageal reflux disease (GERD), esophagitis is assessed by the presence of metaplasia, ulcer, stricture, or erosion, each being graded as absent, mild or severe. Daily reflux symptoms affect about 4 to 7 percent of the population; erosive esophagitis occurs in about 2 percent; the prevalence rate of Barrett's metaplasia is 0.4 percent; and esophageal adenocarcinoma leads to two deaths per million living population. In persons with GERD symptoms, about 20 percent are found to have erosive esophagitis, while ulcers or strictures are found in less than 5 percent of all patients with erosive esophagitis. No clear-cut temporal progression exists between successive grades of disease severity, as the most severe grade of GERD is reached at the onset of the disease. Mild forms of GERD tend to be more common in women than men, while severe GERD characterized by erosive esophagitis, esophageal ulcer, stricture or Barrett's metaplasia are far more common in men than women. All forms of GERD affect Caucasians more often than African Americans or Native Americans. The prevalence of GERD is high among developed countries in North America and Europe and relatively low in developing countries in Africa and Asia. During the past three decades, hospital discharges and mortality rates of gastric cancer, gastric ulcer and duodenal ulcer have declined, while those of esophageal adenocarcinoma and GERD have markedly risen. These opposing time trends suggest that corpus gastritis secondary to Helicobacter pylori infection protects against GERD. This hypothesis is consistent with the geographic and ethnic distributions of GERD. Case-control studies also indicate that cases with erosive esophagitis are less likely to harbor active or chronic corpus gastritis than controls without esophagitis.

Entities:  

Mesh:

Year:  1999        PMID: 10780569      PMCID: PMC2579001     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  36 in total

1.  Prevalence of oesophagitis in asthmatics.

Authors:  S J Sontag; T G Schnell; T Q Miller; S Khandelwal; S O'Connell; G Chejfec; H Greenlee; U J Seidel; L Brand
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

3.  A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis.

Authors:  B I Hirschowitz
Journal:  Gastroenterology       Date:  1991-11       Impact factor: 22.682

4.  Barrett's esophagus. Prevalence and incidence of adenocarcinoma.

Authors:  W A Williamson; F H Ellis; S P Gibb; D M Shahian; H T Aretz; G J Heatley; E Watkins
Journal:  Arch Intern Med       Date:  1991-11

5.  The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden.

Authors:  L Lööf; P Götell; B Elfberg
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

6.  Significant role of aspirin use in patients with esophagitis.

Authors:  A Lanas; B I Hirschowitz
Journal:  J Clin Gastroenterol       Date:  1991-12       Impact factor: 3.062

7.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

8.  Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class.

Authors:  H M Malaty; D G Evans; D J Evans; D Y Graham
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

9.  Reflux esophagitis in patients with Zollinger-Ellison syndrome.

Authors:  L S Miller; R Vinayek; H Frucht; J D Gardner; R T Jensen; P N Maton
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

10.  Symptoms in gastro-oesophageal reflux disease.

Authors:  A G Klauser; N E Schindlbeck; S A Müller-Lissner
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

View more
  21 in total

1.  A Comparison Study of Esophageal Findings on (18)F-FDG PET/CT and Esophagogastroduodenoscopy.

Authors:  KwanHyeong Jo; Soyoung Kim; Jongtae Cha; Sang Hyun Hwang; Narae Lee; Mijin Yun; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-16

2.  Occupational mortality from squamous cell carcinoma of the esophagus in the United States during 1991-1996.

Authors:  Claudia Cucino; Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.

Authors:  Xiao-Jun Yang; Hong-Mei Jiang; Xiao-Hua Hou; Jun Song
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 4.  Erosive tooth wear - a review on global prevalence and on its prevalence in risk groups.

Authors:  N Schlueter; B Luka
Journal:  Br Dent J       Date:  2018-03-02       Impact factor: 1.626

5.  Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Authors:  Roger Jones; Silke Horbach; Peter Sander; Tina Rydén-Bergsten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Barrett's esophagus on repeat endoscopy: should we look more than once?

Authors:  Sarah Rodriguez; Nora Mattek; David Lieberman; Brian Fennerty; Glenn Eisen
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

Review 7.  Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Authors:  Malcolm Robinson; John Horn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  [Motility disorders of the esophagus].

Authors:  E Bruder; A-L Rougemont; R I Furlano; J F Schneider; J Mayr; F-M Haecker; K Beier; J Schneider; P Weber; T Berberich; G Cathomas; W A Meier-Ruge
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

9.  Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination.

Authors:  Juan Du; Jiang Liu; Hong Zhang; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.

Authors:  Amrita Ahluwalia; Dolgor Baatar; Michael K Jones; Andrzej S Tarnawski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.